CoChat

The Identification and Pharmacological Characterization of 6-( tert -Butylsulfonyl)- N -(5-fluoro-1 H -indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase

Open access
Haile, Pamela A., Votta, Bartholomew J., Marquis, Robert W., Bury, Michael J., Mehlmann, John F., Singhaus, Robert, Charnley, Adam K., Lakdawala, Ami S., Convery, Máire A., Lipshutz, David B., Desai, Biva M., Swift, Barbara, Capriotti, Carol A., Berger, Scott B., Mahajan, Mukesh K., Reilly, Michael A., Rivera, Elizabeth J., Sun, Helen H., Nagilla, Rakesh, Beal, Allison M., Finger, Joshua N., Cook, Michael N., King, Bryan W., Ouellette, Michael T., Totoritis, Rachel D., Pierdomenico, Maria, Negroni, Anna, Stronati, Laura, Cucchiara, Salvatore, Ziółkowski, Bartłomiej, Vossenkämper, Anna, MacDonald, Thomas T., Gough, Peter J., Bertin, John, Casillas, Linda N. · 2016 · Journal of Medicinal Chemistry
Cited by 119

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

RIP2 kinase is a central component of the innate immune system and enables downstream signaling following activation of the pattern recognition receptors NOD1 and NOD2, leading to the production of inflammatory cytokines. Recently, several inhibitors of RIP2 kinase have been disclosed that have contributed to the fundamental understanding of the role of RIP2 in this pathway. However, because they lack either broad kinase selectivity or strong affinity for RIP2, these tools have only limited utility to assess the role of RIP2 in complex environments. We present, herein, the discovery and pharmacological characterization of GSK583, a next-generation RIP2 inhibitor possessing exquisite selectivity and potency. Having demonstrated the pharmacological precision of this tool compound, we report its use in elucidating the role of RIP2 kinase in a variety of in vitro, in vivo, and ex vivo experiments, further clarifying our understanding of the role of RIP2 in NOD1 and NOD2 mediated disease pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.6b00211

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 119

Metadata

Authors
Haile, P. A., Votta, B. J., Marquis, R. W., Bury, M. J., Mehlmann, J. F., Singhaus, R., Charnley, A. K., Lakdawala, A. S., Convery, M. A., Lipshutz, D. B., Desai, B. M., Swift, B., Capriotti, C. A., Berger, S. B., Mahajan, M. K., Reilly, M. A., Rivera, E. J., Sun, H. H., Nagilla, R., Beal, A. M., Finger, J. N., Cook, M. N., King, B. W., Ouellette, M. T., Totoritis, R. D., Pierdomenico, M., Negroni, A., Stronati, L., Cucchiara, S., Ziółkowski, B., Vossenkämper, A., MacDonald, T. T., Gough, P. J., Bertin, J., & Casillas, L. N.
Venue
Journal of Medicinal Chemistry
Published
2016-05-04
Volume
59
Issue
10
Pages
4867-4880
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2343417001
Cited by
119
References
3
FWCI
5.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Identification and Pharmacological Characterization of 6-( tert -Butylsulfonyl)- N -(5-fluoro-1 H -indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase. https://app.cochat.ai/papers/10.1021/acs.jmedchem.6b00211
The paper
Haile, P. A., Votta, B. J., Marquis, R. W., Bury, M. J., Mehlmann, J. F., Singhaus, R., Charnley, A. K., Lakdawala, A. S., Convery, M. A., Lipshutz, D. B., Desai, B. M., Swift, B., Capriotti, C. A., Berger, S. B., Mahajan, M. K., Reilly, M. A., Rivera, E. J., Sun, H. H., Nagilla, R., . . . Casillas, L. N. (2016). The Identification and Pharmacological Characterization of 6-( tert -Butylsulfonyl)- N -(5-fluoro-1 H -indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6b00211

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.